Atlas Trials

Effect of Interleukin-1 Receptor Antagonist on Inhalation of 20,000 EU Clinical Ctr Reference Endotoxin in Normal Volunteers

Clinical trial NCT01369017 · COMPLETED

Trial details

NCT number
NCT01369017
Sponsor
Michelle Hernandez, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Control Subjects
Start date
2011-10-01
Primary completion
2013-07-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.